Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Comparing the effects of chemical Ca2+ dyes and R-GECO on contractility and Ca2+ transients in adult and human iPSC cardiomyocytes.

Robinson P. et al, (2023), J Mol Cell Cardiol, 180, 44 - 57

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy

Margara F. et al, (2022), Scientific Reports, 12

Pathogenesis of Cardiomyopathy Caused by Variants in ALPK3, an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere.

Agarwal R. et al, (2022), Circulation

Filamin C Cardiomyopathy Variants Cause Protein and Lysosome Accumulation

Agarwal R. et al, (2021), Circulation Research

Include forthcoming?